[Glomus tumor of the stomach. Report of two cases and review of the literature (author's transl)].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Hashimoto.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A sensitivie and specific radioimmunoassay for the measurement of serum ursodeoxycholic acid has been developed. Ursodeoxycholic acid bound to bovine serum albumin was used as an antigen, and antiserum to this antigen was raised in the rabbit. [11, 12-3h2]Ursodeoxycholic acid was used as the radioactive tracer, and the radioimmunoassay was carried out by the method of Simmonds et al. (1973. Gastroenterology. 65: 705-711). The percentage of bound radioactivity decreased linearly with a logarithmic increase in unlabeled ursodeoxycholic acid from 10 to 200 pmol. The antiserum showed extremely high specificity for ursodeoxycholic acid (free and conjugated), and the values determined by radioimmunoassay indicated a close correlation with those found by gas-liquid chromatography. In normal Japanese subjects, a small amount of ursodeoxycholic acid in serum was detected, and the level was detected, and the level was 0.15 +/- 0.11 nmol/ml. This convenient radioimmunoassay will provide useful information about the metabolism of ursodeoxycholic acid in man.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Antihypertensive and pharmacological properties of budralazine were examined in comparison with other antihypertensive drugs. Budralazine was orally effective against various types of hypertension in rats and it, like reserpine but unlike hydralazine, produced a much greater pressure reduction in hypertensive than in normotensive rats. The drug was similar to reserpine and alpha-methyldopa but not to hydralazine in showing a gradually progressive action. At equihypotensive oral doses, budralazine was less potent than hydralazine in producing tachycardia in unrestrained SHR. After long-term therapy, it effectively prevented the development of hypertension in SHR to almost the same extent as did hydralazine. Budralazine failed to produce diuresis in SHR at antihypertensive doses but antagonized isolated rabbit aortic contractions induced by vasoconstrictors and decreased femoral arterial resistance in dogs. Thus, the antihypertensive budralazine is characterized by the ability to produce vasodilator, non-diuretic and weak cardiac stimulant effects.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Out of 32 R plasmids isolated from Proteus strains, 17 were found to be temperature sensitive with respect to inheritance in E. coli cells. They were fi- and classified into incompatibility group T or V. Cells carrying T group Rms273 plasmid were temperature sensitive with respect to growth and conjugal transfer in both E. coli and Proteus. The V group YOR-10 plasmid was stable in Proteus even at 42 C. However, the loss frequency of YOR-10 plasmid in E. coli reached 100% after 4 hr of incubation at 42 C, in spite of stable inheritance at 25 C. Conjugal transfer of the YOR-10 plasmid in E. coli was also strongly inhibited at 42 C. It has been concluded that instability of V group R plasmids in E. coli is due to their thermosensitive inheritance in the progeny cells at high temperatures.
It is reported that nifedipine, a newly developed antianginal agent, was dramatically effective to suppress the repeatedly occurring ventricular fibrillation in 2 cases of variant form of angina pectoris.
In this study, 131I-labeled human plasma fibrinogen (200 muCi) was injected intravenously into 21 patients with rheumatoid arthritis and 10 control patients without rheumatic diseases. The residual rates of radioiodinated fibrinogen in the knee joints were calculated by measuring with a scintillation counter the microautoradiographs of the synovial tissue obtained by punch biopsy from the knee joints. The residual rates in the knee joints without as well as with objective symptoms of RA were higher than in control patients. Radio-iodinated fibrinogen was demonstrated on the synovial villous surface, on the area of inflammatory cellular infiltration and stromal necrosis, and on the perivascular region of the synovial tissue from the knee joints of patients with RA, not only with, but also without clinical objective symptoms and histopathologic findings of fibrinoid necrosis, vascular superficial fibrinoid coating and fibrinoid degeneration of vascular wall. It is suggested that fibrinogen plays a role even in the early synovial tissue lesions of knee joints affected by RA.
Explore the source record for details and available documents.
Explore the source record for details and available documents.